Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

EMA expects regulatory evaluation of advanced therapies to gather pace in EU

This article was originally published in Clinica

Executive Summary

The European Medicines Agency's Committee for Advanced Therapies says it expects to see more marketing authorisation applications for advanced therapy medicinal products being submitted for review over the next few years in view of the growing R&D pipeline in this sector. In 2013 alone, it expects to receive three to four new marketing applications.

Advertisement

Topics

UsernamePublicRestriction

Register